Intravenous azithromycin-induced ototoxicity
Intravenous azithromycin-induced ototoxicity
复制标题
DOI:
10.1592/phco.19.3.245.30930
复制
发表时间:
1999-02-01
期刊:
影响因子:
4.1
通讯作者:
Dresing, JM
中科院分区:
文献类型:
--
作者:
Bizjak, ED;Haug, MT;Dresing, JM
Intravenous azithromycin is increasingly administered for treatment of hospitalized patients with community-acquired pneumonia. Macrolide antibiotics cause ototoxicity, which occurs most frequently when high serum concentrations are achieved. Current dosing guidelines for intravenous azithromycin can result in much higher serum concentrations than is seen with oral administration. We describe a 47-year-old woman who developed complete deafness after receiving 8 days of intravenous azithromycin.